Analysed VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) News Sources
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
26-05-2026
yahoo.com
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
09-07-2026
yahoo.com
Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX)
09-07-2026
advfn.com
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
09-07-2026
yahoo.com
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
10-07-2026
yahoo.com
Virax Biolabs enters immune profiling product supply deal with Fosun
13-07-2026
hospitalmanagement.net
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
16-07-2026
yahoo.com
What is the current price of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The current price of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is $3.1.
VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) since the previous trading day is $-0.09.
VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) since the previous trading day is -2.8213%.
What is the most recent average sentiment score for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The most recent average sentiment score for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)?
The most recent sentiment for VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ) is .
SEC-8K** Filing Available For VIRAX BIOLABS GROUP LTD (VRAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.